PARP inhibitors for BRCA wild type ovarian cancer; gene alterations, homologous recombination deficiency and combination therapy

Koji Matsumoto, Meiko Nishimura, Takuma Onoe, Hideki Sakai, Yusaku Urakawa, Takashi Onda, Nobuo Yaegashi

Research output: Contribution to journalReview articlepeer-review

24 Citations (Scopus)

Fingerprint

Dive into the research topics of 'PARP inhibitors for BRCA wild type ovarian cancer; gene alterations, homologous recombination deficiency and combination therapy'. Together they form a unique fingerprint.

Medicine and Dentistry

Keyphrases